Ritobegron

DB12080

small molecule investigational

Deskripsi

Ritobegron is under investigation in clinical trial NCT02256735 (Study to Investigate the Effect of KUC 7483 CL on the QT/QTc Interval of the ECG in Comparison to Placebo and Moxifloxacin in Healthy Male and Female Volunteers).

Struktur Molekul 2D

Berat 373.449
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1014 Data
Valsartan Ritobegron may decrease the antihypertensive activities of Valsartan.
Ramipril Ritobegron may decrease the antihypertensive activities of Ramipril.
Remikiren Ritobegron may decrease the antihypertensive activities of Remikiren.
Torasemide Ritobegron may decrease the antihypertensive activities of Torasemide.
Isradipine Ritobegron may decrease the antihypertensive activities of Isradipine.
Olmesartan Ritobegron may decrease the antihypertensive activities of Olmesartan.
Chlorthalidone Ritobegron may decrease the antihypertensive activities of Chlorthalidone.
Nitroprusside Ritobegron may decrease the antihypertensive activities of Nitroprusside.
Diltiazem Ritobegron may decrease the antihypertensive activities of Diltiazem.
Minoxidil Ritobegron may decrease the antihypertensive activities of Minoxidil.
Treprostinil Ritobegron may decrease the antihypertensive activities of Treprostinil.
Amlodipine Ritobegron may decrease the antihypertensive activities of Amlodipine.
Nimodipine Ritobegron may decrease the antihypertensive activities of Nimodipine.
Nisoldipine Ritobegron may decrease the antihypertensive activities of Nisoldipine.
Bendroflumethiazide Ritobegron may decrease the antihypertensive activities of Bendroflumethiazide.
Fosinopril Ritobegron may decrease the antihypertensive activities of Fosinopril.
Trandolapril Ritobegron may decrease the antihypertensive activities of Trandolapril.
Metolazone Ritobegron may decrease the antihypertensive activities of Metolazone.
Lercanidipine Ritobegron may decrease the antihypertensive activities of Lercanidipine.
Benazepril Ritobegron may decrease the antihypertensive activities of Benazepril.
Bosentan Ritobegron may decrease the antihypertensive activities of Bosentan.
Enalapril Ritobegron may decrease the antihypertensive activities of Enalapril.
Cyclothiazide Ritobegron may decrease the antihypertensive activities of Cyclothiazide.
Candoxatril Ritobegron may decrease the antihypertensive activities of Candoxatril.
Mecamylamine Ritobegron may decrease the antihypertensive activities of Mecamylamine.
Losartan Ritobegron may decrease the antihypertensive activities of Losartan.
Moexipril Ritobegron may decrease the antihypertensive activities of Moexipril.
Eplerenone Ritobegron may decrease the antihypertensive activities of Eplerenone.
Lisinopril Ritobegron may decrease the antihypertensive activities of Lisinopril.
Nitroglycerin Ritobegron may decrease the antihypertensive activities of Nitroglycerin.
Metyrosine Ritobegron may decrease the antihypertensive activities of Metyrosine.
Hydroflumethiazide Ritobegron may decrease the antihypertensive activities of Hydroflumethiazide.
Cryptenamine Ritobegron may decrease the antihypertensive activities of Cryptenamine.
Perindopril Ritobegron may decrease the antihypertensive activities of Perindopril.
Candesartan cilexetil Ritobegron may decrease the antihypertensive activities of Candesartan cilexetil.
Fenoldopam Ritobegron may decrease the antihypertensive activities of Fenoldopam.
Indapamide Ritobegron may decrease the antihypertensive activities of Indapamide.
Tadalafil Ritobegron may decrease the antihypertensive activities of Tadalafil.
Eprosartan Ritobegron may decrease the antihypertensive activities of Eprosartan.
Chlorothiazide Ritobegron may decrease the antihypertensive activities of Chlorothiazide.
Quinapril Ritobegron may decrease the antihypertensive activities of Quinapril.
Telmisartan Ritobegron may decrease the antihypertensive activities of Telmisartan.
Methyldopa Ritobegron may decrease the antihypertensive activities of Methyldopa.
Hydrochlorothiazide Ritobegron may decrease the antihypertensive activities of Hydrochlorothiazide.
Trichlormethiazide Ritobegron may decrease the antihypertensive activities of Trichlormethiazide.
Irbesartan Ritobegron may decrease the antihypertensive activities of Irbesartan.
Nitrendipine Ritobegron may decrease the antihypertensive activities of Nitrendipine.
Deserpidine Ritobegron may decrease the antihypertensive activities of Deserpidine.
Pentolinium Ritobegron may decrease the antihypertensive activities of Pentolinium.
Trimethaphan Ritobegron may decrease the antihypertensive activities of Trimethaphan.
Diazoxide Ritobegron may decrease the antihypertensive activities of Diazoxide.
Captopril Ritobegron may decrease the antihypertensive activities of Captopril.
Epoprostenol Ritobegron may decrease the antihypertensive activities of Epoprostenol.
Bepridil Ritobegron may decrease the antihypertensive activities of Bepridil.
Hydralazine Ritobegron may decrease the antihypertensive activities of Hydralazine.
Polythiazide Ritobegron may decrease the antihypertensive activities of Polythiazide.
Cilazapril Ritobegron may decrease the antihypertensive activities of Cilazapril.
Saprisartan Ritobegron may decrease the antihypertensive activities of Saprisartan.
Spirapril Ritobegron may decrease the antihypertensive activities of Spirapril.
Mibefradil Ritobegron may decrease the antihypertensive activities of Mibefradil.
Tienilic acid Ritobegron may decrease the antihypertensive activities of Tienilic acid.
Debrisoquine Ritobegron may decrease the antihypertensive activities of Debrisoquine.
Sitaxentan Ritobegron may decrease the antihypertensive activities of Sitaxentan.
Ambrisentan Ritobegron may decrease the antihypertensive activities of Ambrisentan.
Diethylnorspermine Ritobegron may decrease the antihypertensive activities of Diethylnorspermine.
Nilvadipine Ritobegron may decrease the antihypertensive activities of Nilvadipine.
Pinacidil Ritobegron may decrease the antihypertensive activities of Pinacidil.
Temocapril Ritobegron may decrease the antihypertensive activities of Temocapril.
Riociguat Ritobegron may decrease the antihypertensive activities of Riociguat.
Macitentan Ritobegron may decrease the antihypertensive activities of Macitentan.
Hexamethonium Ritobegron may decrease the antihypertensive activities of Hexamethonium.
Aliskiren Ritobegron may decrease the antihypertensive activities of Aliskiren.
Nicorandil Ritobegron may decrease the antihypertensive activities of Nicorandil.
Efonidipine Ritobegron may decrease the antihypertensive activities of Efonidipine.
Lacidipine Ritobegron may decrease the antihypertensive activities of Lacidipine.
Manidipine Ritobegron may decrease the antihypertensive activities of Manidipine.
Rauwolfia serpentina root Ritobegron may decrease the antihypertensive activities of Rauwolfia serpentina root.
Enalaprilat Ritobegron may decrease the antihypertensive activities of Enalaprilat.
Selexipag Ritobegron may decrease the antihypertensive activities of Selexipag.
Angiotensin 1-7 Ritobegron may decrease the antihypertensive activities of Angiotensin 1-7.
Imidapril Ritobegron may decrease the antihypertensive activities of Imidapril.
BQ-123 Ritobegron may decrease the antihypertensive activities of BQ-123.
Cicletanine Ritobegron may decrease the antihypertensive activities of Cicletanine.
Dihydralazine Ritobegron may decrease the antihypertensive activities of Dihydralazine.
Zofenopril Ritobegron may decrease the antihypertensive activities of Zofenopril.
Guanoxan Ritobegron may decrease the antihypertensive activities of Guanoxan.
Delapril Ritobegron may decrease the antihypertensive activities of Delapril.
Vincamine Ritobegron may decrease the antihypertensive activities of Vincamine.
Linsidomine Ritobegron may decrease the antihypertensive activities of Linsidomine.
Guanoxabenz Ritobegron may decrease the antihypertensive activities of Guanoxabenz.
Tolonidine Ritobegron may decrease the antihypertensive activities of Tolonidine.
Endralazine Ritobegron may decrease the antihypertensive activities of Endralazine.
Cadralazine Ritobegron may decrease the antihypertensive activities of Cadralazine.
Cyclopenthiazide Ritobegron may decrease the antihypertensive activities of Cyclopenthiazide.
Bietaserpine Ritobegron may decrease the antihypertensive activities of Bietaserpine.
Guanazodine Ritobegron may decrease the antihypertensive activities of Guanazodine.
Methoserpidine Ritobegron may decrease the antihypertensive activities of Methoserpidine.
Guanoclor Ritobegron may decrease the antihypertensive activities of Guanoclor.
Muzolimine Ritobegron may decrease the antihypertensive activities of Muzolimine.
Xipamide Ritobegron may decrease the antihypertensive activities of Xipamide.

Target Protein

Beta-3 adrenergic receptor ADRB3

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul